Five-Minute Apgar Scores and Its Prognostic Value for Mortality and Severe Morbidity in Very Preterm Infants: A Multinational Cohort Study
- PMID: 40661038
- DOI: 10.1111/1471-0528.18291
Five-Minute Apgar Scores and Its Prognostic Value for Mortality and Severe Morbidity in Very Preterm Infants: A Multinational Cohort Study
Abstract
Objective: To examine associations between a 5-min Apgar score < 7 and severe neonatal outcomes in very preterm (VPT) infants and how results are impacted by variations in assigning Apgar scores within an international context.
Design: Prospective observational population-based cohort study.
Setting: Eleven structurally and organisationally diverse countries across Europe.
Population: In total, 7900 liveborn VPT infants from the EPICE-SHIPS study.
Methods: Descriptive statistics, logistic regression, modified Poisson regression.
Main outcome measures: Associations between 5-min Apgar scores < 7 and adverse neonatal outcomes were estimated with adjustments for perinatal characteristics. We tested for interactions by country-level prevalence of an Apgar score < 7, grouped into low (14%-16%), medium (19%-22%) and high (28%-40%).
Results: 20.2% of infants had 5-min Apgar score < 7 with rates of 14%-40% across countries. A score < 7 increased risks of in-hospital mortality, intraventricular haemorrhage (IVH), cystic periventricular leukomalacia (cPVL), retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD) and length of hospital stay (LHS), but not necrotising enterocolitis or late-onset infection (LOI). No interactions with country group were detected for mortality, cPVL and ROP, while associations with IVH, BPD and LHS were restricted to countries with lower prevalence of scores < 7.
Conclusions: Significant differences exist in the prevalence of low Apgar scores across countries. Their interactions with adverse outcomes demand caution when using the Apgar score in prognostic models for clinical care and research without local validation. More broadly, our findings emphasise the importance of accounting for country-specific effects in clinical assessment scores.
Keywords: Apgar score; bronchopulmonary dysplasia; intraventricular haemorrhage; mortality; preterm infant; prognostic factor; retinopathy of prematurity.
© 2025 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
References
-
- S. Iliodromiti, D. F. Mackay, G. C. S. Smith, J. P. Pell, and S. M. Nelson, “Apgar Score and the Risk of Cause‐Specific Infant Mortality: A Population‐Based Cohort Study,” Lancet 384, no. 9956 (2014): 1749–1755, https://doi.org/10.1016/S0140‐6736(14)61135‐1.
-
- N. Razaz, W. T. Boyce, M. Brownell, et al., “Five‐Minute Apgar Score as a Marker for Developmental Vulnerability at 5 Years of Age,” Archives of Disease in Childhood 101, no. 2 (2016): F114–F120, https://doi.org/10.1136/archdischild‐2015‐308458.
-
- J. Hong, K. Crawford, K. Jarrett, T. Triggs, and S. Kumar, “Five‐Minute Apgar Score and Risk of Neonatal Mortality, Severe Neurological Morbidity and Severe Non‐Neurological Morbidity in Term Infants–An Australian Population‐Based Cohort Study,” Lancet Regional Health ‐ Western Pacific 44 (2024): 101011, https://doi.org/10.1016/j.lanwpc.2024.101011.
-
- N. Razaz, M. Norman, T. Alfvén, et al., “Low Apgar Score and Asphyxia Complications at Birth and Risk of Longer‐Term Cardiovascular Disease: A Nationwide Population‐Based Study of Term Infants,” Lancet Regional Health ‐ Europe 24 (2022): 100532, https://doi.org/10.1016/j.lanepe.2022.10053.
-
- S. Cnattingius, S. Johansson, and N. Razaz, “Apgar Score and Risk of Neonatal Death Among Preterm Infants,” New England Journal of Medicine 383, no. 1 (2020): 49–57, https://doi.org/10.1056/NEJMoa1915075.
Grants and funding
LinkOut - more resources
Full Text Sources